Introduction {#S0001}
============

Lysosomes are membrane-bound acidic organelles that serve as "recycle centers" in almost all animal cells. Equipped with over 60 hydrolases, lysosomes are capable of degrading macromolecules including proteins, polysaccharides, and lipids to their building units for material re-use and energy homeostasis \[[1](#CIT0001)\]. Lysosomes can fuse with "cargo" vesicles to receive substrates from both intracellular sources (autophagy via autophagosomes) and extracellular sources (endocytosis and phagocytosis via endosomes and phagosomes) \[[2](#CIT0002)\] and can transport products of degradation (e.g. amino acids, fatty acids and monosaccharides) out of lysosomes by transporters or membrane trafficking \[[3](#CIT0003)\].

Besides luminal hydrolases, lysosomes also harbor more than 50 types of proteins on their limiting membranes, with a number of them confirmed as transporters and ion channels. A still expanding list includes: V-ATPase as the proton pump that acidify lysosome lumen; NPC1 that transport cholesterol; SLC38A9 that senses and transports arginine; and TRPMLs, TPCs, BK, TMEM175, P2X4, CLCs as ion channels. These proteins play crucial roles in maintaining lysosomal homeostasis which is optimized for hydrolases activities, transporter activities and membrane trafficking \[[1](#CIT0001)\]. Moreover, the recently revealed mechanisms of how mTORC1 docks on lysosome surface and then regulates the balance of cellular growth and autophagy suggests that lysosomes are far more than merely cellular waste bags, but rather key players in intracellular nutrient and energy sensing and signaling \[[4](#CIT0004),[5](#CIT0005)\].

Reactive oxygen species (ROS) were first considered only as harmful chemical species that causes oxidative damage to molecules such as DNA, proteins, and lipids in cells, but were later on also considered to work as second messengers in redox signaling that can regulate a variety of biological processes \[[6](#CIT0006)--[8](#CIT0008)\]. In line with this notion, evidence suggested that autophagy can be regulated by ROS \[[9](#CIT0009)\]. Whether lysosomes can be directly affected by ROS in autophagy regulation was however unclear. Also, whether and how lysosomes' other diverse functions (e.g. exocytosis, vesicular trafficking, Ca^2+^ signaling) can be regulated by intracellular redox signals remain unclear open questions.

When considering the identity of redox sensors on organelles like lysosomes, it is natural to think about membrane proteins. Among them, ion channels are particularly "suspicious" because they can undergo redox modulations and can be activated/deactivated, thus are capable of sensing diverse stimuli including chemical signals. A number of ion channels have actually been identified as redox sensors on plasma membrane or other organelles \[[10](#CIT0010)--[15](#CIT0015)\].

However, studying lysosomal ion channels could be technically challenging because of lysosomes' small sizes (100--500 nm in diameter), dynamic motility as well as their active fusion and fission \[[1](#CIT0001)\]. Fortunately, with the development of techniques such as whole-lysosome patch-clamp \[[16](#CIT0016)\] and planar patch clamp \[[17](#CIT0017)\], together with lysosome-specific immunofluorescence, it is now possible to record current through lysosome memebranes, therefore, made it possible to characterize lysosomal ion channels under various conditions.

Here in this review, we will summarize recent findings that indicate one ion channel, TRPML1, as the first redox sensor on lysosomes that mediate ROS-induced autophagy and also discuss other lysosomal ion channels that might potentially respond to redox signaling.

The first identified redox sensor on lysosomes: TRPML1 {#S0002}
======================================================

Transient receptor potential mucolipin 1 (TRPML1), encoded by the *MCOLN1* gene, is an ion channel that belongs to the mammalian mucolipin subfamily of the transient receptor potential (TRP) superfamily of cation channels \[[18](#CIT0018)\]. TRPML1 is a Ca^2+^-permeable, nonselective cation channel that is mainly localized on late endosomes and lysosomes (LELs). Loss of function mutations of human TRPML1 leads to a lysosomal storage disease (LSD) named Mucolipidosis type IV disease (ML-IV), manifesting lysosomal storage and deficiency in lysosomal trafficking \[[18](#CIT0018)--[20](#CIT0020)\]. Studies during the past decade have revealed that TRPML1 serves as the primary Ca^2+^ release channel on lysosomes and is a key player in regulating multifaceted lysosomal functions including lysosomal exocytosis \[[21](#CIT0021)--[23](#CIT0023)\], nutrient sensing \[[24](#CIT0024)\], lysosome motility \[[25](#CIT0025)\], autophagy \[[26](#CIT0026)\] and of most interest to this review, oxidative stress sensing \[[27](#CIT0027)\].

In a study by Zhang et al. \[[27](#CIT0027)\], the authors reported for the first time that lysosomal TRPML1 current can be activated directly by oxidants such as hydrogen peroxide and chloramine T, or chemicals such as carbonyl cyanide m-chlorophenylhydrazone (CCCP) that can induce mitochondrial ROS production. This activation of TRPML1 by oxidants or ROS is missing in TRPML1 knockout cells and also can be blocked by antioxidants or TRPML1-specific antagonists, suggesting its specificity. Moreover, the TRPML1 current induced by oxidants is quick on lysosome patch-clamps, indicating that it is a direct activation. The authors further studied the consequences of the redox activation of TRPML1 and found that transcription factor EB (TFEB), the master regulator of lysosome biogenesis and autophagy is activated via TRPML1-mediated Ca^2+^ signaling. Not surprisingly, lysosome biogenesis and autophagy levels are both elevated upon TRPML1 activation by oxidants or CCCP treatment. Very interestingly, TRPML1 is not required for autophagy induced by mTOR inhibition, suggestive of a redox-specific role-played by this channel in autophagy regulation. Also, TRPML1 is required for the removal of excessive ROS induced by CCCP, presumably through mitophagy, a specialized autophagy that removes damaged mitochondria.

Redox-sensing ion channels on lysosomes of certain cells: TRPM2 {#S0003}
===============================================================

Besides ion channels that are located on lysosomes in all cell types, some ion channels are localized on lysosomes only in certain cell types. Among them, transient receptor potential melastatin 2 (TRPM2) is one that is most extensively studied.

TRPM2 is a Ca^2+^-permeable nonselective cation channel that belongs to the melastatin subfamily of TRP superfamily \[[28](#CIT0028),[29](#CIT0029)\]. Human TRPM2 is expressed in various tissues, with especially high levels in brain and peripheral blood cells \[[30](#CIT0030)\]. TRPM2 are localized on plasma membrane in most cell types, and can be activated by a variety of stimuli including ADP-ribose (ADPR), ADPR-2ʹ-phosphate (ADPRP), Ca^2+^, heat and oxidative stress \[[28](#CIT0028),[29](#CIT0029),[31](#CIT0031)\]. While it is known that TRPM2 activation leads to Ca^2+^ entry to cells and is linked to diseases like ischemia-reperfusion injury and bipolar disorder, the physiological function of TRPM2 is controversial \[[25](#CIT0025),[28](#CIT0028),[32](#CIT0032),[33](#CIT0033)\]. Very interestingly, TRPM2 is also found on lysosomal membranes of pancreatic β cells and mediates oxidative stress-induced β cell death, as well as on lysosomal membranes of dendritic cells and mediates cell maturation and chemotaxis \[[34](#CIT0034),[35](#CIT0035)\]. Moreover, recent evidence suggests TRPM2 can also reside on lysosomal membranes in cancer cells and modulate their migration by regulating actin remodeling \[[36](#CIT0036)\]. Plus, oxidative-stress-induced activation of lysosomal TRPM2 not only triggers the release of Ca^2+^, but also Zn^2+^ from lysosomes \[[36](#CIT0036),[37](#CIT0037)\]. These findings suggest that TRPM2-mediated cytosolic Zn^2+^ elevation is also closely involved in pancreatic β cells death and actin cytoskeleton remodeling, although the identity of the responsible Zn^2+^ transporter is still unclear. Altogether, lysosomal TRPM2 appears to play complex physiological functions associated with specific cell types.

Other possible redox-sensing lysosomal ion channels {#S0004}
===================================================

In addition to the channels discussed above, there still might be more redox-sensing ion channels on lysosomes. For example, large conductance Ca^2+^-activated K^+^ channels (also known as BK for Big Potassium, Maxi-K, or Slo1), first found on plasma membranes, are reported to be modulated by oxidizing and reducing reagents {DiChiara, 1997 \#241}. Accumulating evidence suggests that cysteines and methionines on BK undergo complex oxidation, which consequently affect their channel property \[for a detailed review, see [13](#CIT0013)\]. BK channel on mitochondria (mitoBK) is a crucial regulator of mitochondrial function and ROS generation \[[38](#CIT0038)--[41](#CIT0041)\]. In recent studies, BK is discovered to also be a lysosomal potassium channel that facilitates TRPML1 functions and lysosomal Ca^2+^ store maintenance \[[42](#CIT0042),[43](#CIT0043)\]. Whether lysosomal BK also undergoes same oxidation modulation would be an interesting question to explore. TMEM175, another lysosomal potassium channel, has been reported to affect lysosome functions, mitochondrial respiration, and pathogenesis of Parkinson's disease \[[44](#CIT0044),[45](#CIT0045)\]. It is still unclear whether TMEM175 is directly involved in redox sensing. Chloride channel CLC-3 has been reported to be a lysosomal channel \[[46](#CIT0046)\] and can mediate ROS signaling \[[47](#CIT0047)\]. A recent study also indicated that CLC-3 current can be activated by ROS induced by zoledronic acid (ZA) \[[48](#CIT0048)\]. Although it is now more accepted that CLC-3 is localized predominantly on early and late endosomes while CLC-7 is the major chloride channel on lysosomes \[[1](#CIT0001),[49](#CIT0049),[50](#CIT0050)\], it would be interesting to check whether CLC-7 shows similar redox-sensitivity.

Redox-sensing lysosomal ion channels and diseases {#S0005}
=================================================

Elevated ROS is a common feature of many LSDs \[[51](#CIT0051),[52](#CIT0052)\]. Interestingly, several of them are linked with compromised TRPML1 functions. Fibroblasts from ML-IV patients have constitutively higher ROS when compared to fibroblasts from normal persons \[[27](#CIT0027)\]. In line with this, knockdown of TRPML1 in retinal pigmented epithelial 1 (RPE1) cells leads to mitochondria fragmentation and ROS buildup \[[53](#CIT0053)\]. In Niemann--Pick Disease Type C (NPC), another LSD, associated with defected NPC1 or NPC2 proteins and the consequent lysosomal accumulation of lipids such as cholesterol, TRPML1 channel activity is reduced by 70% \[[54](#CIT0054)\] while ROS level is elevated when compared with WT fibroblasts \[[27](#CIT0027),[55](#CIT0055)\]. Similarly, Fabry disease, an X-linked LSD caused by alpha galactosidase (GLA) deficiency and the accumulation of its substrates such as globotriaosylceramide (Gb3), also manifest decreased TRPML1 activity \[[56](#CIT0056)\] and abnormal redox status, including increased ROS generation in cultured Fabry endothelial cells \[[57](#CIT0057)\] as well as increased oxidative damage to macromolecules in Fabry patients \[[58](#CIT0058)\]. Altogether, these data indicate that defected TRPML1 activity might be a common feature for different LSDs. Considering TRPML1's role in removal of excessive ROS, whether restoring TRPML1 genetically or pharmaceutically can alleviate the abnormal oxidative stress and improve cells' healthiness in these diseases will be tempting to test. It is also worth exploring whether other LSDs with similar redox imbalance also features similar TRPML1 function defects.

Besides LSDs, emerging evidence suggests that TRPML1 is also important for cancer cell survival \[[59](#CIT0059)--[61](#CIT0061)\]. Interestingly, the effect of TRPML1 activity modulation on cancer cell survival differs, possibly dependent on the type of cancers and stimuli. Specifically, TRPML1 inhibition suppresses the growth of triple-negative breast cancers (TNBCs) \[[59](#CIT0059)\] and reduces the proliferation of oncogenic *HRAS*-expressing cancer cells \[[61](#CIT0061)\]. On the other hand, a very recent research reported that glioblastoma (GBM) patients survival are negatively correlated with TRPML1 expression level, while glioma cells are vulnerable to ROS when TRPML1 is activated \[[60](#CIT0060)\].

As mentioned earlier in this review, although TRPM2 has been linked to multiple diseases, lysosomal TRPM2 appears to show specialized functions in immune cells. Besides β cells and dendritic cells, TRPM2 has also been reported to localize on lysosomes in peritoneal macrophages in a recent study \[[62](#CIT0062)\]. Interestingly, TRPM2 knockout leads to decreased phagosome-lysosome fusion in macrophages, resulting disrupted phagosome acidification and bacterial killing. In line with this, TRPM2 knockout mice also appeared to have impaired clearance of invading bacteria and thus sepsis. This new finding provided a hint that lysosomal TRPM2 might facilitate the fusion of lysosome with other organelles to fulfill their responsible functions.

Concluding remarks {#S0006}
==================

Sensing redox cues in the environment is not only a task cells need to handle but also challenges to intracellular organelles. Lysosomes, as key organelle that coordinate intracellular homeostasis, are no exceptions to these challenges. Here we summarized recent discoveries that indicate lysosomal ion channels as potential redox sensors (for a summary, see [Figure 1](#F0001)).10.1080/19336950.2019.1684428-F0001Figure 1.Ion channels as potential redox sensors in lysosomes.A schematic summary of the lysosomal ion channels as potential redox sensors reviewed in this article. TRPML1 can be activated by intracellular ROS, leading to Ca^2+^ release, followed by TFEB activation and autophagy boost. TRPM2, found on the lysosomes of immune cells, are indirectly activated by ROS via ADPR, resulting an increase of intracellular Ca^2+^ and Zn^2+^, which are closely involved in β cell death and actin remodeling. BK channels on plasma membrane undergo complex oxidation modulation, whether lysosomal BK can be regulated by the same mechanism is unclear. Similarly, more work is needed for the role of redox status on other lysosomal channels such as TMEM175 and CLCs.

The identification of TRPML1 as lysosomal redox sensor filled a long missing link between ROS and autophagy thus is of high significance. Also, this finding easily raises more follow-up questions. Cell biology-wise, whether and how do ROS affect other TRPML1-mediated lysosome functions (such as lysosome motility, lysosome tabulation, and reformation, lysosomal exocytosis and membrane trafficking)? Does lysosome respond to different levels of ROS differently? Physiology-wise, would the correction of elevated ROS in TRPML1 k.o. cells alleviate symptoms of diseases caused by TRPML1 deficiency (e.g. ML-IV, NPC)? Mechanism-wise, how exactly does TRPML1 get activated by redox signals? With the newly solved structures of TRPML1 \[[63](#CIT0063)--[65](#CIT0065)\], more details on the biochemical and structural changes of TRPML1 upon redox-regulation can be expected. Similarly, the latest discovery of zebrafish TRPM2's structures at resting and active states has also shed light on possible mechanisms how this channel is activated/sensitized by oxidative signals \[[66](#CIT0066)\].

Whether there are more lysosomal ion channel redox sensors? To answer this question, on the one hand, knowledge of the identity and channel property of more lysosomal channels will be needed; on the other hand, ion channels that function on lysosome only in specialized cells (such as TRPM2, TRPA1) add another level of complexity to the question and will require more thorough understanding of cell type-specific channel distribution and functions.

Altogether, researches on lysosomal ion channels' redox-sensing properties are only in its early stage, but could be of great value. The accumulation of structural information of these channels, together with the findings of more channel-specific agonists/antagonists, could make them a group of potential drug targets for disorders that features disrupted redox signaling.
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